Clinical Trial Update: Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eradication of Helicobacter pylori with a proton pump inhibitor versus control has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Positive Helicobacter Pylori Serology, Coronary Thrombosis | Phase 4 | Status: WITHDRAWN